RECENT NEWS

Researchers from Thomas Jefferson University and the University of Maryland School of Medicine have reported encouraging results from the first human clinical trial of LASSARAB, an experimental vaccine designed to protect against Lassa fever and rabies in a single formulation.

Genomics England has announced that Baroness Nicola Blackwood will step down as Chair at the end of 2026 as she comes to the end of her tenure.

Scientists at King’s College London have discovered a new way of designing antibiotics which could support the discovery of new treatments for drug-resistant infections, as well as reviving antibiotics that have lost effectiveness due to antimicrobial resistance.

Precision medicine firm SOPHiA GENETICS has announced the formation of a joint venture combining Memorial Sloan Kettering Cancer Center’s innovation in clinical diagnostics with its own AI platform to develop precision oncology treatments.

The first clinical trial of a ‘universal’ Sarbeco coronavirus vaccine at two National Institute for Health and Care Research (NIHR) facilities has shown that the vaccine is safe and has no significant side effects.

Italian life sciences and diagnostics company Tethis has announced the commercial launch of SmartBioSurface slides, an innovative solution designed to transform the analysis of rare and suspension cells.

A new report calls for redesign of NHS diagnostic services as one in five patients are currently waiting longer than the NHS target of six weeks, against a backdrop of rising demand that could see the waiting list pass two million people next year.

Thermo Fisher Scientific has expanded its suite of Orbitrap mass spectrometry platforms, AI-enabled software and integrated workflows, which all made their debut at the American Society for Mass Spectrometry (ASMS) Conference.

Roche has announced that it developed a Research Use Only (RUO) molecular PCR test, via its subsidiary TIB MOLBIOL, to detect the rare Ebola Bundibugyo virus. The test was developed within just six days.

The government has announced over £20 million of funding to improve prostate cancer research and treatment, alongside the introduction of a targeted prostate cancer screening programme.

Diagnostics firm QuidelOrtho has joined with the Allo Hope Foundation, a nonprofit dedicated to supporting families and clinicians managing maternal alloimmunisation, for a new collaboration focused on improving prenatal care through education, early testing and stronger connections between laboratory providers, clinicians and patients.

Spectral flow cytometry company Cytek Biosciences is launching its new seven-laser Cytek Borealis full spectrum flow cytometer at CYTO 2026, the industry’s premier flow cytometry conference,

Beckman Coulter Life Sciences has announced the commercial release of the Echo 650 Plus Series acoustic liquid handlers - introducing next‑generation electronics, enhanced acoustic performance, and a 54% reduction in power consumption to increase reliability, lower operating costs, and support sustainability goals in high‑throughput laboratories.

A Mount Sinai-led research team has demonstrated that autoimmunity is responsible for the often-debilitating and confounding symptoms of long COVID in a subset of people.

Developer of rapid AST (antimicrobial susceptibility testing) technology iFAST Diagnostics, has announced it has successfully closed a £5 million funding round.

The Health Research Authority (HRA) has launched a two-year plan to help support the safe and trusted use of artificial intelligence (AI) in health and social care research across the UK.

On Thursday 4 June, hospital laboratories, universities and biomedical science teams across the UK are marking Biomedical Science Day 2026 - the 10th celebration of the national awareness day dedicated to the profession behind diagnosis, treatment and disease monitoring.

Scottish Brain Sciences (SBS) has launched a new and accredited clinical laboratory service offering blood‑based biomarker and cerebrospinal fluid (CSF) testing for Alzheimer’s disease. The service increases Scotland’s capacity to provide faster, more accurate and more accessible diagnostic support for clinicians and healthcare providers across the UK.

LotusDx, a medtech company developing at-home diagnostic tests for sexually transmitted infections (STIs), has established its R&D laboratory at ONE BioHub, located on the Foresterhill Health Campus, in Aberdeen.

Leica Biosystems has announced the expansion of a collaboration to scale precision medicine and develop AI-powered diagnostics. The Danaher company is working with AstraZeneca and Daiichi Sankyo to develop an end-to-end system for TROP2 NMR in non-small cell lung cancer.